Monte Rosa Therapeutics, Inc.Monte Rosa Therapeutics, Inc.Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

No trades
See on Supercharts

Price target

15.710.00 0.00%
The 7 analysts offering 1 year price forecasts for GLUE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to GLUE in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned